Skip to main content
. 2020 Dec 17;16(1):168–181. doi: 10.1016/j.stemcr.2020.11.010

Figure 5.

Figure 5

Recovered hiPSC-CMs Show Altered Drug Responses at the Monolayer Level

(A–D) Drug-induced changes in FPDc in line 1 fresh and recovered hiPSC-CMs.

(E–H) Drug-induced changes in FPDc in line 2 fresh and recovered hiPSC-CMs.

(I–L) Drug-induced changes in FPDc in line 3 fresh and recovered hiPSC-CMs.

(M–P) Drug-induced changes in FPDc in line 4 fresh and recovered hiPSC-CMs.

(Q–T) Drug-induced changes in FPDc in line 5 fresh and recovered hiPSC-CMs. Color-coded marks (X) indicate no measurements under that drug treatment condition due to drug-induced cardiac arrest.

All data represented as mean ± SEM, from three to six independent measurements, ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001 compared with their respective fresh samples at the same dose.